Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction (Q58874452)
scientific article published on 01 October 1998
Language:
(P31) (Q13442814)
(P50) (Q42110577)
(Q42110588)
(P304) 535-538
(P407) (Q1860)
(P433) 4
(P478) 42
(P577) Thursday, October 1, 1998
(P921) (Q25419)
(Q808845)
(Q2870929)
(P1433) (Q6294770)
(P1476) "Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction" (language: en)
(P2093) M del Cuerpo
M Sabaté
B Mirelis
G Prats
other details
description scientific article published on 01 October 1998

External Links